Spironolactone And Hydrochlorothiazide Tablet
Product Images NDC 53489-144

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Spironolactone And Hydrochlorothiazide (NDC 53489-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

Chemical structure diagram of Spironolactone, showing its molecular framework with labeled carbon and oxygen atoms. The structure features characteristic steroid rings and functional groups consistent with the active ingredient in Spironolactone and Hydrochlorothiazide tablets by Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Figure (Spironolactone 02)

Chemical structure diagram of Spironolactone and Hydrochlorothiazide showing atomic connectivity and molecular framework for these active ingredients.*

FDA Label Image

Container Label (Spironolactone 03)

Label for Spironolactone and Hydrochlorothiazide Tablets USP, 25 mg/25 mg strength, oral tablet form. The label indicates it is a prescription drug (Rx Only) supplied in a bottle of 100 tablets. The labeler is Sun Pharmaceutical Industries, Inc. It includes dosage instructions, NDC 53489-144-01, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.